Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

AMS:CTAC - Euronext Amsterdam - NL0000345577 - Common Stock - Currency: EUR

3.46  +0.57 (+19.72%)

Fundamental Rating

4

Overall CTAC gets a fundamental rating of 4 out of 10. We evaluated CTAC against 70 industry peers in the IT Services industry. While CTAC seems to be doing ok healthwise, there are quite some concerns on its profitability. CTAC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CTAC was profitable.
In the past year CTAC had a positive cash flow from operations.
Each year in the past 5 years CTAC has been profitable.
Each year in the past 5 years CTAC had a positive operating cash flow.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

1.2 Ratios

With a Return On Assets value of 1.35%, CTAC is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
CTAC's Return On Equity of 3.23% is on the low side compared to the rest of the industry. CTAC is outperformed by 61.33% of its industry peers.
CTAC has a Return On Invested Capital of 6.93%. This is comparable to the rest of the industry: CTAC outperforms 48.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTAC is below the industry average of 11.01%.
Industry RankSector Rank
ROA 1.35%
ROE 3.23%
ROIC 6.93%
ROA(3y)4.54%
ROA(5y)4.22%
ROE(3y)12.11%
ROE(5y)11.26%
ROIC(3y)8.2%
ROIC(5y)7.33%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 0.73%, CTAC is doing worse than 60.00% of the companies in the same industry.
CTAC's Profit Margin has declined in the last couple of years.
CTAC's Operating Margin of 3.68% is on the low side compared to the rest of the industry. CTAC is outperformed by 61.33% of its industry peers.
CTAC's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.49%, CTAC is in line with its industry, outperforming 42.67% of the companies in the same industry.
CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.68%
PM (TTM) 0.73%
GM 56.49%
OM growth 3Y-11.2%
OM growth 5Y6.06%
PM growth 3Y-40.07%
PM growth 5Y-18.4%
GM growth 3Y-5.02%
GM growth 5Y-3.21%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CTAC is still creating some value.
CTAC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTAC has more shares outstanding
The debt/assets ratio for CTAC has been reduced compared to a year ago.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.06 indicates that CTAC is not in any danger for bankruptcy at the moment.
CTAC's Altman-Z score of 3.06 is fine compared to the rest of the industry. CTAC outperforms 70.67% of its industry peers.
The Debt to FCF ratio of CTAC is 1.48, which is an excellent value as it means it would take CTAC, only 1.48 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.48, CTAC belongs to the top of the industry, outperforming 81.33% of the companies in the same industry.
CTAC has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.24, CTAC is doing good in the industry, outperforming 69.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.48
Altman-Z 3.06
ROIC/WACC1.09
WACC6.39%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.3 Liquidity

A Current Ratio of 0.96 indicates that CTAC may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.96, CTAC is doing worse than 69.33% of the companies in the same industry.
CTAC has a Quick Ratio of 0.96. This is a bad value and indicates that CTAC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CTAC (0.95) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.95
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CTAC have decreased strongly by -77.82% in the last year.
CTAC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.20% yearly.
CTAC shows a decrease in Revenue. In the last year, the revenue decreased by -1.36%.
CTAC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.92% yearly.
EPS 1Y (TTM)-77.82%
EPS 3Y-32.52%
EPS 5Y-11.2%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)-1.36%
Revenue growth 3Y13.37%
Revenue growth 5Y8.92%
Sales Q2Q%-4.65%

3.2 Future

Based on estimates for the next years, CTAC will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.01% on average per year.
CTAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.52% yearly.
EPS Next Y-5.34%
EPS Next 2Y15.75%
EPS Next 3Y17.01%
EPS Next 5YN/A
Revenue Next Year-5.41%
Revenue Next 2Y0.72%
Revenue Next 3Y2.21%
Revenue Next 5Y5.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.1 0.2 0.3 0.4 0.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CTAC is valuated quite expensively with a Price/Earnings ratio of 57.67.
Compared to the rest of the industry, the Price/Earnings ratio of CTAC indicates a slightly more expensive valuation: CTAC is more expensive than 60.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, CTAC is valued quite expensively.
A Price/Forward Earnings ratio of 7.37 indicates a rather cheap valuation of CTAC.
89.33% of the companies in the same industry are more expensive than CTAC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CTAC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 57.67
Fwd PE 7.37
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTAC indicates a somewhat cheap valuation: CTAC is cheaper than 76.00% of the companies listed in the same industry.
77.33% of the companies in the same industry are more expensive than CTAC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.82
EV/EBITDA 5.79
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as CTAC's earnings are expected to grow with 17.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.75%
EPS Next 3Y17.01%

More info and screens

6

5. Dividend

5.1 Amount

CTAC has a Yearly Dividend Yield of 3.81%.
Compared to an average industry Dividend Yield of 4.29, CTAC pays a bit more dividend than its industry peers.
CTAC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 3.81%

5.2 History

On average, the dividend of CTAC grows each year by 9.23%, which is quite nice.
Dividend Growth(5Y)9.23%
Div Incr Years2
Div Non Decr Years5
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

171.18% of the earnings are spent on dividend by CTAC. This is not a sustainable payout ratio.
The dividend of CTAC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP171.18%
EPS Next 2Y15.75%
EPS Next 3Y17.01%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

CTAC NV

AMS:CTAC (3/7/2025, 7:00:00 PM)

3.46

+0.57 (+19.72%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.27%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap48.96M
Analysts85
Price Target3.83 (10.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.81%
Yearly Dividend0.06
Dividend Growth(5Y)9.23%
DP171.18%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.79%
PT rev (3m)-12.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.98%
Revenue NY rev (3m)-12.98%
Valuation
Industry RankSector Rank
PE 57.67
Fwd PE 7.37
P/S 0.39
P/FCF 7.82
P/OCF 6.3
P/B 1.74
P/tB 28.48
EV/EBITDA 5.79
EPS(TTM)0.06
EY1.73%
EPS(NY)0.47
Fwd EY13.56%
FCF(TTM)0.44
FCFY12.78%
OCF(TTM)0.55
OCFY15.88%
SpS8.78
BVpS1.99
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE 3.23%
ROCE 12.57%
ROIC 6.93%
ROICexc 7.42%
ROICexgc 33.43%
OM 3.68%
PM (TTM) 0.73%
GM 56.49%
FCFM 5.04%
ROA(3y)4.54%
ROA(5y)4.22%
ROE(3y)12.11%
ROE(5y)11.26%
ROIC(3y)8.2%
ROIC(5y)7.33%
ROICexc(3y)10.43%
ROICexc(5y)9.33%
ROICexgc(3y)115.51%
ROICexgc(5y)96.92%
ROCE(3y)15.25%
ROCE(5y)13.62%
ROICexcg growth 3Y-7.66%
ROICexcg growth 5Y7.54%
ROICexc growth 3Y-3.42%
ROICexc growth 5Y6.27%
OM growth 3Y-11.2%
OM growth 5Y6.06%
PM growth 3Y-40.07%
PM growth 5Y-18.4%
GM growth 3Y-5.02%
GM growth 5Y-3.21%
F-Score5
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.48
Debt/EBITDA 0.7
Cap/Depr 29.93%
Cap/Sales 1.22%
Interest Coverage 10.94
Cash Conversion 80.67%
Profit Quality 688.56%
Current Ratio 0.96
Quick Ratio 0.95
Altman-Z 3.06
F-Score5
WACC6.39%
ROIC/WACC1.09
Cap/Depr(3y)24.57%
Cap/Depr(5y)22.66%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.17%
Profit Quality(3y)407.05%
Profit Quality(5y)446.86%
High Growth Momentum
Growth
EPS 1Y (TTM)-77.82%
EPS 3Y-32.52%
EPS 5Y-11.2%
EPS Q2Q%-4.35%
EPS Next Y-5.34%
EPS Next 2Y15.75%
EPS Next 3Y17.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.36%
Revenue growth 3Y13.37%
Revenue growth 5Y8.92%
Sales Q2Q%-4.65%
Revenue Next Year-5.41%
Revenue Next 2Y0.72%
Revenue Next 3Y2.21%
Revenue Next 5Y5.52%
EBIT growth 1Y-26.4%
EBIT growth 3Y0.68%
EBIT growth 5Y15.52%
EBIT Next Year37.61%
EBIT Next 3Y27.33%
EBIT Next 5YN/A
FCF growth 1Y39.8%
FCF growth 3Y-14.6%
FCF growth 5Y22.16%
OCF growth 1Y43.71%
OCF growth 3Y-10.97%
OCF growth 5Y14.71%